These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 33838964)

  • 1. Immunohistochemical expression levels of cyclin D1 and CREPT reflect the course and prognosis in oral precancerous lesions and squamous cell carcinoma.
    Siril YJ; Kouketsu A; Saito H; Takahashi T; Kumamoto H
    Int J Oral Maxillofac Surg; 2022 Jan; 51(1):27-32. PubMed ID: 33838964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knocking-down of CREPT prohibits the progression of oral squamous cell carcinoma and suppresses cyclin D1 and c-Myc expression.
    Ma J; Ren Y; Zhang L; Kong X; Wang T; Shi Y; Bu R
    PLoS One; 2017; 12(4):e0174309. PubMed ID: 28369091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expressions of FHIT and cyclin D1/CDK4 in oral cancer and oral precancerous lesions].
    Yin C; Shen LJ; Xie SM; Ruan P; Yao X
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Jul; 25(7):812-4. PubMed ID: 16027075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of cyclin D1 correlates with p27
    Guan G; Bakr MM; Firth N; Love RM
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Aug; 126(2):174-183. PubMed ID: 29550080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin D1 expression and its possible regulation in chewing tobacco mediated oral squamous cell carcinoma progression.
    Mishra R; Das BR
    Arch Oral Biol; 2009 Oct; 54(10):917-23. PubMed ID: 19679297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin D1 expression in oral squamous cell carcinoma and verrucous carcinoma: correlation with histological differentiation.
    Angadi PV; Krishnapillai R
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):e30-5. PubMed ID: 17197212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daxx and TCF4 interaction links to oral squamous cell carcinoma growth by promoting cell cycle progression via induction of cyclin D1 expression.
    Lin GJ; Huang YS; Lin CK; Huang SH; Shih HM; Sytwu HK; Chen YW
    Clin Oral Investig; 2016 Apr; 20(3):533-40. PubMed ID: 26205068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical assessment of growth factor signaling molecules: MAPK, Akt, and STAT3 pathways in oral epithelial precursor lesions and squamous cell carcinoma.
    Tashiro K; Oikawa M; Miki Y; Takahashi T; Kumamoto H
    Odontology; 2020 Jan; 108(1):91-101. PubMed ID: 31062130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical Expression Of Cyclind1 In Conventional Squamous Cell Carcinomaof Oral Cavity.
    Rauf M; Azmat H; Shahab S; Ahmad A; Khadija S; Firidi J
    J Ayub Med Coll Abbottabad; 2023; 35(1):11-16. PubMed ID: 36849369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression and its significance of Cyclin D1 in oral squamous cell carcinoma].
    Xing JS; Shi PR; Chen XJ; He DN; Li LH; Nan XR
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2011 Jun; 29(3):299-301, 305. PubMed ID: 21776860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical Expression of Cyclin D1 and Ki-67 in Primary and Metastatic Oral Squamous Cell Carcinoma.
    Nazar M; Naz I; Mahmood MK; Hashmi SN
    Asian Pac J Cancer Prev; 2020 Jan; 21(1):37-41. PubMed ID: 31983161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma.
    Soni S; Kaur J; Kumar A; Chakravarti N; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
    Oncology; 2005; 68(4-6):314-25. PubMed ID: 16020958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of immunoregulatory molecules PD-L1 and PD-1 in oral cancer and precancerous lesions: A cohort study of Japanese patients.
    Kouketsu A; Sato I; Oikawa M; Shimizu Y; Saito H; Takahashi T; Kumamoto H
    J Craniomaxillofac Surg; 2019 Jan; 47(1):33-40. PubMed ID: 30466788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of tumor suppressor gene PTEN, PIP3 and cyclin D1 in oral squamous cell carcinoma and their correlations].
    Xie SM; Shen LJ; Yin C; Ruan P; Yao X
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2006 Jul; 41(7):407-10. PubMed ID: 17067457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin d1 expression and its correlation with histopathological differentiation in oral squamous cell carcinoma.
    Saawarn S; Astekar M; Saawarn N; Dhakar N; Gomateshwar Sagari S
    ScientificWorldJournal; 2012; 2012():978327. PubMed ID: 22629227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expressions of PTEN and FHIT in oral squamous cell carcinoma and their relations with cyclin D1].
    Shen LJ; Xie SM; Yin C; Ruan P; Yao X
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Jan; 25(1):79-82. PubMed ID: 15684005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of cyclin D1 expression with aggressive DNA pattern in patients with tobacco-related intraoral squamous cell carcinoma.
    Das SN; Khare P; Singh MK; Sharma SC
    Indian J Med Res; 2011 Apr; 133(4):381-6. PubMed ID: 21537090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical assessment of Eph/ephrin expression in oral squamous cell carcinoma and precursor lesions.
    Saito H; Oikawa M; Kouketsu A; Takahashi T; Kumamoto H
    Odontology; 2020 Apr; 108(2):166-173. PubMed ID: 31654153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-501-3p restricts prostate cancer growth through regulating cell cycle-related and expression-elevated protein in tumor/cyclin D1 signaling.
    Zhang Z; Shao L; Wang Y; Luo X
    Biochem Biophys Res Commun; 2019 Feb; 509(3):746-752. PubMed ID: 30621914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrative analysis of gene alterations and immunoexpression profiles of cell cycle checkpoints in oral squamous cell carcinoma.
    Pérez-Sayáns M; Chamorro-Petronacci CM; Lorenzo-Pouso AI; Peñaranda JMS; López-López J; Blanco-Carrión A; García-García A
    Cancer Biomark; 2020; 27(1):95-103. PubMed ID: 31683463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.